Covid-19 Vaccine | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Monday
January 30, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
MONDAY, JANUARY 30, 2023

Covid-19 Vaccine

Representational image. Picture: Collected
Covid-19 in Bangladesh

16 children to get trial Covid jabs on Thursday

A full-fledged vaccination campaign to follow for children ages 5-11, starting 25 August

Moderna has recently signed vaccine orders for 2022 worth $17 billion — which would make it one of the best-selling drugs in the world. Photo: Reuters
Coronavirus chronicle

Japan study shows women more likely to get skin rash from Moderna shot

People pass the control tower of Singapore's Changi Airport, Singapore January 18, 2021. Photo :Reuters
Coronavirus chronicle

Singapore extends quarantine-free entry as Asia shifts to "living with Covid"

Photo: Courtesy
Covid-19 in Bangladesh

3.25cr to be inoculated on 17-31 March

Photo: Courtesy
Covid-19 in Bangladesh

Permanent vaccine centres still offering first dose against Covid

Illustration: TBS
Covid-19 in Bangladesh

More funds incoming from dev partners for vaccine purchase

EIB provides €250m for Covid immunisation in Bangladesh
Covid-19 in Bangladesh

EIB provides €250m for Covid immunisation in Bangladesh

The chief trial investigator for the vaccine said that he's optimistic about reaching that point before the end of this year Photo: Bloomberg
Coronavirus chronicle

Poorer nations dump millions of close-to-expiry Covid-19 vaccines - UNICEF

Photo: Courtesy
Covid-19 in Bangladesh

Half of targeted population to be inoculated with vaccines of Covax, gifts

Vials with a sticker reading, "Covid-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration
Coronavirus chronicle

US CDC advisers to weigh limits on J&J vaccine due to blood clot issues -Washington Post

Representational photo.
Covid-19 in Bangladesh

Covid booster doses to start within 7-10 days: Health Minister

A vial labelled with the Pfizer-BioNTech coronavirus disease (Covid-19) vaccine is seen in this illustration picture taken March 19, 2021. Photo :Reuters
Coronavirus chronicle

Pfizer set to oust AstraZeneca as top supplier of Covid-19 shots to poor nations

18 August, Jakarta. Family and friends mourn at the graveside of a Covid-19 victim at the Rorotan cemetery. Photo: Dimas Ardian/Bloomberg
Panorama

How a year full of vaccine promise turned into another Covid-19 nightmare

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net